Growth Metrics

Palvella Therapeutics (PVLA) Receivables Refunds (2013 - 2015)

Palvella Therapeutics (PVLA) reported Receivables Refunds of $3534.0 for Q3 2015, down 77.93% on a QoQ basis from $16015.0 in Q2 2015.

Palvella Therapeutics (PVLA) has 3 years of Receivables Refunds data on file, last reported at $3534.0 in Q3 2015.

  • Quarterly Receivables Refunds changed N/A year-over-year to $3534.0 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $3534.0 (changed N/A YoY) and the FY2014 annual result came in at $14810.0, down 77.72% from the prior year.
  • Receivables Refunds slipped to $3534.0 in Q3 2015 per PVLA's latest filing, from $16015.0 in the prior quarter.
  • Across five years, Receivables Refunds topped out at $66479.0 in Q4 2013 and bottomed at $3534.0 in Q3 2015.
  • The 3-year median for Receivables Refunds is $15232.0 (2015), against an average of $23214.0.
  • Peak annual rise in Receivables Refunds reached 77.72% in 2014, while the deepest fall reached 77.72% in 2014.
  • Tracing PVLA's Receivables Refunds over 3 years: stood at $66479.0 in 2013, then tumbled by 77.72% to $14810.0 in 2014, then plunged by 76.14% to $3534.0 in 2015.
  • Per Business Quant, the three latest PVLA Receivables Refunds figures stand at $3534.0 (Q3 2015), $16015.0 (Q2 2015), and $15232.0 (Q1 2015).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Refund Receivables (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Palvella Therapeutics 1.47 Bn 1.21 Bn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2015 3,534.00
Jun 30, 2015 16,015.00
Mar 31, 2015 15,232.00
Dec 31, 2014 14,810.00
Dec 31, 2013 66,479.00